在结肠直肠癌中KRAS/NRAS和BRAF突变的分子模式和临床影响
İvo Gökmen1, Ebru Taştekin2, Nazan Demir3
1Division of Medical Oncology, Department of Internal Medicine, Trakya University School of Medicine, Edirne 22030, Turkey.
Current issues in molecular biology
|October 27, 2023
概括
这项研究在结直肠癌 (CRC) 患者中发现了KRAS,NRAS和BRAF突变. 在老年患者,女性和右侧结肠瘤中,NRAS/BRAF突变更为常见.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- KRAS,NRAS和BRAF突变是结直肠癌 (CRC) 的关键驱动因素.
- 了解突变模式和临床关联对于CRC的向治疗至关重要.
研究的目的:
- 确定CRC中KRAS,NRAS和BRAF突变的发生率和分子模式.
- 调查这些突变与临床参数之间的关联.
主要方法:
- 下一代测序 (NGS) 用于分析KRAS,NRAS和BRAF突变.
- 记录了检测率和患者人口统计数据.
- 奇平方测试被用来评估突变和临床因素之间的关系.
主要成果:
- 在332/694名患者中发现了KRAS突变,其中KRAS G12D是最常见的. 还确定了非典型的变体.
- NRAS突变发生在4.5%的患者中,L80W作为一种非典型的变异.
- 在5.3%的患者中存在BRAF突变,主要是BRAF V600E. NRAS/BRAF突变与年龄较大 (>64岁),女性性别和右侧结肠瘤有关.
结论:
- 该研究确定了CRC中KRAS,NRAS和BRAF的特定突变模式和频率.
- 观察到NRAS/BRAF突变与患者人口统计学/瘤位置之间存在关联.
- 这些发现有助于理解CRC分子格局和潜在的治疗点.
更多相关视频
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
13.8K
10:16Employing Digital Droplet PCR to Detect BRAF V600E Mutations in Formalin-fixed Paraffin-embedded Reference Standard Cell Lines
Published on: October 8, 2015
13.3K
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
